Roger Garceau
Director/Board Member at ENTERA BIO LTD.
Net worth: 103 845 $ as of 2024-05-30
Roger Garceau active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENTERA BIO LTD. | Director/Board Member | 2016-02-29 | - |
| Chief Executive Officer | 2020-08-09 | 2021-01-03 | |
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 2018-12-31 | - |
| Independent Dir/Board Member | 2018-12-31 | - | |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Director/Board Member | 2015-05-03 | - |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Board Member | 2016-11-30 | - |
| Independent Dir/Board Member | 2016-11-30 | - |
Career history of Roger Garceau
Former positions of Roger Garceau
| Companies | Position | Start | End |
|---|---|---|---|
| NPS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2009-06-10 | 2015-01-31 |
| Sales & Marketing | 2008-12-10 | 2009-06-10 | |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Director/Board Member | 2018-12-31 | - |
Training of Roger Garceau
| Fairfield University | Undergraduate Degree |
| UMass Chan Medical School | Doctorate Degree |
Statistics
International
| United States | 7 |
| France | 2 |
| Israel | 2 |
Operational
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ENTERA BIO LTD. | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Fluorinov Pharmaceuticals, Inc.
Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Health Technology |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Roger Garceau
- Experience
